0001209191-23-024898.txt : 20230419 0001209191-23-024898.hdr.sgml : 20230419 20230419180011 ACCESSION NUMBER: 0001209191-23-024898 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230417 FILED AS OF DATE: 20230419 DATE AS OF CHANGE: 20230419 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TIDMARSH GEORGE F CENTRAL INDEX KEY: 0001287235 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39603 FILM NUMBER: 23830947 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REVELATION BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001810560 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 843898466 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4660 LAJOLLA VILLAGE DRIVE STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 650-800-3717 MAIL ADDRESS: STREET 1: 4660 LAJOLLA VILLAGE DRIVE STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: Petra Acquisition Inc. DATE OF NAME CHANGE: 20200423 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-04-17 0 0001810560 REVELATION BIOSCIENCES, INC. REVB 0001287235 TIDMARSH GEORGE F C/O REVELATION BIOSCIENCES, INC. 4660 LA JOLLA VILLAGE DR., SUITE 100 SAN DIEGO CA 92122 1 0 0 0 0 Common Stock 2023-04-17 4 P 0 26500 1.16 A 39848 D Common Stock 2023-04-18 4 P 0 25000 1.16 A 64848 D Common Stock 43525 I By Trust Represents the weighted-average price at which shares were purchased within a range between $1.14 and $1.17. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Shares are held by George Tidmarsh, Trustee George Francis Tidmarsh 2021 Irrevocable Trust with respect to which George Tidmarsh is a trustee. /s/ J.P. Galda, as attorney-in-fact for George F Tidmarsh 2023-04-19